FDA Town Hall

10:45 AM - 11:30 AM (EDT), Tuesday, June 6, 2023 ・ Session Room 205ABC

Join us for a hybrid discussion with the directors of the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER) of the U.S. Food and Drug Administration (FDA). Topics will include center priorities, staffing, and navigating changes from the COVID-19 pandemic.

Moderator

Richard Pops

Chairman and Chief Executive Officer

Alkermes, Inc.

Speakers

Peter Marks, MD, PhD

Director, Center for Biologics Evaluation and Research (CBER)

U.S. Food and Drug Administration

Patrizia Cavazzoni, MD

Director, Center for Drug Evaluation and Research

FDA